Llwytho...
Miltefosine for the treatment of cutaneous leishmaniasis—A pilot study from Ethiopia
BACKGROUND: Cutaneous leishmaniasis (CL) in Ethiopia, caused by Leishmania aethiopica, is often severe and hard to treat compared to CL caused by other species elsewhere. Miltefosine is the only oral anti-leishmanial drug, with a favorable side-effect profile compared to routinely available sodium s...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | PLoS Negl Trop Dis |
|---|---|
| Prif Awduron: | , , , , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Public Library of Science
2021
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8191986/ https://ncbi.nlm.nih.gov/pubmed/34048461 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0009460 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|